Available IPD datapackage for study 'A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)'

Name: Available IPD datapackage for study 'A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)'
Creator: Vivli
Published: 2021-12-16T23:16:01+08:00

DataCite Commons2024-12-02 更新2026-05-07 收录

2型糖尿病药物治疗

GLP-1

数据链接：

https://search.vivli.org/doiLanding/dataPackages/PR00004504_0 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of the study is to assess the benefits and risks of once-weekly dulaglutide compared to once-daily liraglutide in participants with type 2 diabetes who have inadequate glycemic control on metformin.

提供机构：

Vivli

创建时间：

2021-12-16